ACADIA PHARMACEUTICALS INC. Other Nonoperating Expense
ACADIA PHARMACEUTICALS INC. (ACAD) reported Other Nonoperating Expense of $12.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2019-08-01
- ACADIA PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2019-06-30 was $12.00K, a 95.14% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2019-03-31 was $229.00K.
- ACADIA PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2018-12-31 was -$127.00K.
- ACADIA PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2018-09-30 was $1.72M.
- ACADIA PHARMACEUTICALS INC. other nonoperating expense for fiscal 2018 was $1.84M.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2019-06-30 | $12.00K 10-Q · filed 2019-08-01 | $241.00K 10-Q · filed 2019-08-01 | $114.00K derived: sum of 3 quarters · filed 2019-08-01 | $1.83M derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | $229.00K 10-Q · filed 2019-05-02 | $102.00K derived: sum of 2 quarters · filed 2019-05-02 | $1.82M derived: sum of 3 quarters · filed 2019-05-02 | $2.07M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.59M derived: sum of 2 quarters · filed 2019-02-27 | $1.84M derived: sum of 3 quarters · filed 2019-08-01 | $1.84M 10-K · filed 2019-02-27 |
| 2018-09-30 | $1.72M 10-Q · filed 2018-11-06 | $1.97M derived: sum of 2 quarters · filed 2019-08-01 | $1.97M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $247.00K 10-Q · filed 2019-08-01 | $247.00K 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |